{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:07:10Z","timestamp":1790924830441,"version":"4.1.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.autrev.2011.01.008","type":"journal-article","created":{"date-parts":[[2011,2,7]],"date-time":"2011-02-07T09:11:30Z","timestamp":1297069890000},"page":"444-454","source":"Crossref","is-referenced-by-count":178,"title":["Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients"],"prefix":"10.1016","volume":"10","author":[{"given":"Maurizio","family":"Pietrogrande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Linda","family":"Zignego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Pioltelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Sansonno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Sollima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Atzeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Saccardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Quartuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savino","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Campanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Candela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Castelnovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovan Battista","family":"Gaeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Marson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Mascia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Mazzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Mazzotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlomaurizio","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Piccinino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Prati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Puoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piersandro","family":"Riboldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Roccatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelista","family":"Sagnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Scaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Scarpato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Sinico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Taliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Tavoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Bonacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Renoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Filippini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piercarlo","family":"Sarzi-Puttini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clodoveo","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2011.01.008_bb0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0002-9343(62)90191-2","article-title":"Cryoglobulinemia based on interaction between a gamma macroglobulin and 7S gamma globulin","volume":"32","author":"Lospalluto","year":"1962","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2011.01.008_bb0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000206699","article-title":"Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up","volume":"70","author":"Invernizzi","year":"1983","journal-title":"Acta Haematol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0015","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/0002-9343(66)90199-9","article-title":"Cryoglobulinemia \u2014 a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability","volume":"40","author":"Meltzer","year":"1966","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2011.01.008_bb0020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/infdis\/162.2.569","article-title":"Hepatitis C virus in patients with cryoglobulinemia type II","volume":"162","author":"Pascual","year":"1990","journal-title":"J Infect Dis"},{"issue":"S4","key":"10.1016\/j.autrev.2011.01.008_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0277-5379(91)90583-Y","article-title":"Alpha-interferon in the treatment of mixed cryoglobulinemia patients. Proceedings International Cancer Update. Focus on interferon alfa-2b\u2032, Cannes, Nov 1990","volume":"27","author":"Ferri","year":"1991","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.autrev.2011.01.008_bb0030","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0140-6736(92)91562-M","article-title":"Hepatitis C virus and mixed cryoglobulinaemia","volume":"339","author":"Galli","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2011.01.008_bb0035","first-page":"621","article-title":"Association between hepatitis C virus and mixed cryoglobulinemia","volume":"9","author":"Ferri","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1172-3-25","article-title":"Mixed cryoglobulinemia","volume":"3","author":"Ferri","year":"2008","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 3","key":"10.1016\/j.autrev.2011.01.008_bb0045","first-page":"77","article-title":"Preliminary classification criteria for the cryoglobulinemic syndrome","volume":"69","author":"De Vita","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.01.008_bb0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/092986708783330610","article-title":"Current and emerging therapeutic approaches in HCV-related mixed cryoglobulinemia","volume":"15","author":"Sansonno","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.autrev.2011.01.008_bb0055","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/01.BRS.0000065484.95996.AF","article-title":"Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group","volume":"28","author":"van Tulder","year":"2003","journal-title":"Spine"},{"key":"10.1016\/j.autrev.2011.01.008_bb0060","series-title":"Evidence-based medicine: how to practice and teach EBM","author":"Sackett","year":"1997"},{"key":"10.1016\/j.autrev.2011.01.008_bb0065","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.3748\/wjg.v13.i17.2467","article-title":"Hepatitis C virus-related lymphoproliferative disorders: an overview","volume":"13","author":"Zignego","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0070","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/0002-9343(87)90904-1","article-title":"Treatment of idiopathic mixed cryoglobulinemia with alpha interferon","volume":"83","author":"Bonomo","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2011.01.008_bb0075","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood.V78.12.3142.3142","article-title":"Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia","volume":"78","author":"Casato","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.01.008_bb0080","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.dld.2006.06.008","article-title":"Extrahepatic manifestations of hepatitis C virus infection: a general overview and guidelines for a clinical approach","volume":"39","author":"Zignego","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.autrev.2011.01.008_bb0085","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V81.5.1132.1132","article-title":"Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover\u2013controlled trial","volume":"81","author":"Ferri","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.01.008_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF01710739","article-title":"Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients","volume":"21","author":"Ferri","year":"1993","journal-title":"Infection"},{"key":"10.1016\/j.autrev.2011.01.008_bb0095","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0016-5085(93)90862-7","article-title":"Cryoglobulinemia with vasculitis associated with hepatitis C virus infection","volume":"104","author":"Marcellin","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2011.01.008_bb0100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJM199302183280703","article-title":"Membranoproliferative glomerulonephritis associated with hepatitis C virus infection","volume":"328","author":"Johnson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2011.01.008_bb0105","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","article-title":"Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus","volume":"330","author":"Misiani","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2011.01.008_bb0110","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V84.10.3336.3336","article-title":"Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study","volume":"84","author":"Dammacco","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.01.008_bb0115","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/ki.1994.471","article-title":"Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy","volume":"46","author":"Johnson","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2011.01.008_bb0120","first-page":"342","article-title":"Long-term effects of alpha-interferon therapy for type II mixed cryoglobulinemia","volume":"79","author":"Mazzaro","year":"1994","journal-title":"Haematologica"},{"issue":"Suppl 13","key":"10.1016\/j.autrev.2011.01.008_bb0125","first-page":"S181","article-title":"Effects of two different alpha-interferon regimens on clinical and virological findings in mixed cryoglobulinemia","volume":"13","author":"Mazzaro","year":"1995","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 13","key":"10.1016\/j.autrev.2011.01.008_bb0130","first-page":"S175","article-title":"Interferon in the treatment of mixed cryoglobulinemia","volume":"13","author":"Migliaresi","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF02990568","article-title":"Long-term results regarding the use of recombinant interferon alpha-2b in the treatment of II type mixed essential cryoglobulinemia","volume":"12","author":"Lauta","year":"1995","journal-title":"Med Oncol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0140","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/jir.1996.16.585","article-title":"Cryoglobulinemia in hepatitis C virus chronic active hepatitis: effects of interferon-alpha therapy","volume":"16","author":"Casaril","year":"1996","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.autrev.2011.01.008_bb0145","first-page":"81","article-title":"Treatment of mixed cryoglobulinemia with recombinant interferon alpha and adjuvant therapies. A prospective study on 20 patients","volume":"147","author":"Cohen","year":"1996","journal-title":"Ann M\u00e9d Interne (Paris)"},{"key":"10.1016\/j.autrev.2011.01.008_bb0150","first-page":"343","article-title":"Interferon therapy in HCV-positive mixed cryoglobulinemia: viral and host factors contributing to efficacy of the therapy","volume":"29","author":"Mazzaro","year":"1997","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0155","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00004836-199712000-00013","article-title":"Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-alpha","volume":"25","author":"Akriviadis","year":"1997","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0160","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood.V90.10.3865","article-title":"Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection","volume":"90","author":"Casato","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.01.008_bb0165","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00042737-199711000-00008","article-title":"Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinaemia","volume":"9","author":"Adinolfi","year":"1997","journal-title":"Eur Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/gut.45.1.122","article-title":"Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus","volume":"45","author":"Cresta","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2011.01.008_bb0175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0168-8278(97)80281-4","article-title":"Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia","volume":"27","author":"Polzien","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0180","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1046\/j.1440-1746.1999.02015.x","article-title":"Mixed cryoglobulinaemia associated with hepatitis C virus infection: a predictor factor for treatment with interferon?","volume":"14","author":"Pellicano","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0185","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V","article-title":"Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy","volume":"77","author":"Mazzaro","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.autrev.2011.01.008_bb0190","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood.V92.8.2983","article-title":"Interferon and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia","volume":"92","author":"Donada","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.01.008_bb0195","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1046\/j.1365-2036.1999.00581.x","article-title":"Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia","volume":"13","author":"Calleja","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.autrev.2011.01.008_bb0200","first-page":"2172","article-title":"Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha","volume":"27","author":"Zuckerman","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0205","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1002\/art.10699","article-title":"Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis","volume":"46","author":"Cacoub","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.01.008_bb0210","first-page":"1775","article-title":"Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon","volume":"30","author":"Mazzaro","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0215","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/ndt\/gfg209","article-title":"Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency","volume":"18","author":"Bruchfeld","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2011.01.008_bb0220","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1046\/j.1523-1755.2003.00022.x","article-title":"Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy","volume":"63","author":"Rossi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2011.01.008_bb0225","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1182\/blood.V97.6.1555","article-title":"The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection","volume":"97","author":"Zuckerman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.01.008_bb0230","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7326\/0003-4819-137-7-200210010-00008","article-title":"Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas","volume":"137","author":"Zignego","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2011.01.008_bb0235","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood-2002-05-1537","article-title":"Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation","volume":"102","author":"Giannelli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.01.008_bb0240","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2011.01.008_bb0245","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2011.01.008_bb0250","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2011.01.008_bb0255","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2011.01.008_bb0260","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jhep.2004.10.031","article-title":"Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study","volume":"42","author":"Mazzaro","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0265","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.20958","article-title":"PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis","volume":"52","author":"Cacoub","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.01.008_bb0270","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/j.ajkd.2003.11.020","article-title":"Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN","volume":"43","author":"Alric","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2011.01.008_bb0275","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1007\/s10620-006-9355-2","article-title":"Symptomatic and virological response to antiviral therapy in hepatitis C associated with extrahepatic complications of cryoglobulinemia","volume":"52","author":"Joshi","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2011.01.008_bb0280","first-page":"1164","article-title":"Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus","volume":"32","author":"Levine","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0285","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/art.23305","article-title":"Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response","volume":"58","author":"Landau","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.01.008_bb0290","first-page":"1641","article-title":"Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection","volume":"23","author":"La Civita","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0295","first-page":"506","article-title":"Interferon toxicity in hepatitis C virus-associated type II cryoglobulinemia","volume":"16","author":"Di Lullo","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0300","first-page":"403","article-title":"Cryoglobulinemia and hepatitis c: worsening of peripheral neuropathy after interferon alpha treatment","volume":"23","author":"Lidove","year":"1999","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0305","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/1529-0131(199905)42:5<1051::AID-ANR26>3.0.CO;2-Q","article-title":"Interferon-alpha may exacerbate cryoblobulinemia-related ischemic manifestations: an adverse effect potentially related to its anti-angiogenic activity","volume":"42","author":"Cid","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.01.008_bb0310","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mus.10118","article-title":"Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review","volume":"25","author":"Boonyapisit","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2011.01.008_bb0315","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.meg.0000108342.41221.0c","article-title":"Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa","volume":"16","author":"Batisse","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0320","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/01.bor.0000198002.42826.c2","article-title":"Cryoglobulinemic vasculitis","volume":"18","author":"Ferri","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0325","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/BOR.0b013e3282f1330c","article-title":"Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis","volume":"20","author":"Saadoun","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0330","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/ard.2007.081653","article-title":"Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinemia vasculitis","volume":"67","author":"Saadoun","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.01.008_bb0335","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.01.008_bb0340","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.01.008_bb0345","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1093\/ndt\/gfh469","article-title":"Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis","volume":"19","author":"Roccatello","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2011.01.008_bb0350","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clim.2007.06.008","article-title":"Efficacy of low dose rituximab for mixed cryoglobulinemia","volume":"125","author":"Visentini","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0355","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/rheumatology\/kel004","article-title":"Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids","volume":"45","author":"Quartuccio","year":"2006","journal-title":"Rheumatol Oxf"},{"key":"10.1016\/j.autrev.2011.01.008_bb0360","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00004836-200605000-00018","article-title":"J treatment of type II cryoglobulinemia associated with hepatitis C with rituximab","volume":"40","author":"Pekow","year":"2006","journal-title":"Clin Gastroenterol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0365","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1097\/01.tp.0000183749.79424.b4","article-title":"Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients","volume":"80","author":"Basse","year":"2005","journal-title":"Transplantation"},{"issue":"Suppl 57","key":"10.1016\/j.autrev.2011.01.008_bb0370","first-page":"84","article-title":"Efficacy of rituximab in severe and mild abdominal vasculitis in the course of mixed cryoglobulinemia","volume":"28","author":"Quartuccio","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0375","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/art.24703","article-title":"Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis","volume":"60","author":"Terrier","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.01.008_bb0380","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/ard.61.10.922","article-title":"Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab)","volume":"61","author":"Arzoo","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.01.008_bb0385","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1136\/ard.2002.004929","article-title":"Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis","volume":"62","author":"Lamprecht","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.01.008_bb0390","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.ajkd.2003.12.057","article-title":"Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C-negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure","volume":"43","author":"Ghijsels","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2011.01.008_bb0395","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ndt\/gfh564","article-title":"Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab","volume":"20","author":"Koukoulaki","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2011.01.008_bb0400","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/rheumatology\/keh470","article-title":"Serum sickness associated with rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia","volume":"44","author":"Catuogno","year":"2005","journal-title":"Rheumatol Oxf"},{"key":"10.1016\/j.autrev.2011.01.008_bb0405","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1093\/ndt\/gfl266","article-title":"Rituximab induces regression of hepatitis C virus-related membranoproliferative glomerulonephritis in a renal allograft","volume":"21","author":"Bestard","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2011.01.008_bb0410","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ajh.21330","article-title":"Catastrophic multiple organ ischemia due to an anti-Pr cold agglutinin developing in a patient with mixed cryoglobulinemia after treatment with rituximab","volume":"84","author":"Ruch","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0415","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/MCG.0b013e3180f60b7a","article-title":"Rituximab-responsive cryoglobulinemic glomerulonephritis in a patient with autoimmune hepatitis","volume":"42","author":"Evans","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0420","first-page":"27","article-title":"Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia","volume":"66","author":"Korte","year":"2008","journal-title":"Neth J Med"},{"key":"10.1016\/j.autrev.2011.01.008_bb0425","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/S1590-8658(07)80026-0","article-title":"Efficacy and risk of rituximab in type II mixed cryoglobulinemia: a significant case report","volume":"39","author":"Massari","year":"2007","journal-title":"Dig Liver Dis"},{"issue":"Suppl 1","key":"10.1016\/j.autrev.2011.01.008_bb0430","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S1590-8658(07)80025-9","article-title":"Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab","volume":"39","author":"Petrarca","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.autrev.2011.01.008_bb0435","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00296-007-0462-y","article-title":"Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab","volume":"28","author":"Braun","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2011.01.008_bb0440","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.4076\/1757-1626-2-7859","article-title":"Successful combination of rituximab and plasma exchange in the treatment of cryoglobulinemic vasculitis with skin ulcers: a case report","volume":"2","author":"Tallarita","year":"2009","journal-title":"Cases J"},{"key":"10.1016\/j.autrev.2011.01.008_bb0445","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s00415-009-5072-z","article-title":"Rituximab in cryoglobulinemic peripheral neuropathy","volume":"256","author":"Cavallo","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0450","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00296-009-1106-1","article-title":"Long-term efficacy of rituximab in hepatitis C virus-associated cryoglobulinemia","volume":"30","author":"da Silva Fucuta Pereira","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2011.01.008_bb0455","first-page":"196","article-title":"Clinical improvement induced by rituximab in two cases of type II mixed cryoglobulinemia syndrome unresponsive to conventional treatments","volume":"8","author":"Cabibbo","year":"2010","journal-title":"Blood Transfus"},{"key":"10.1016\/j.autrev.2011.01.008_bb0460","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcv.2009.10.006","article-title":"Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: rapid response to treatment with rituximab","volume":"47","author":"Uppal","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0465","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-11-253948","article-title":"Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease","volume":"116","author":"Petrarca","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.01.008_bb0470","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/rheumatology\/keh080","article-title":"Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia","volume":"43","author":"Chandesris","year":"2004","journal-title":"Rheumatol Oxf"},{"key":"10.1016\/j.autrev.2011.01.008_bb0475","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatol Oxf"},{"key":"10.1016\/j.autrev.2011.01.008_bb0480","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/ard.2007.083584","article-title":"Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients","volume":"67","author":"Josselin","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.01.008_bb0485","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.autrev.2008.05.005","article-title":"Hepatitis C virus infection, mixed crioglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune process, or both?","volume":"8","author":"De Vita","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"Suppl 3","key":"10.1016\/j.autrev.2011.01.008_bb0490","first-page":"93","article-title":"A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (RTX) monotherapy versus the best available treatment (BAT) in patients with mixed cryoglobulinemia syndrome (MC)","volume":"69","author":"De Vita","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.01.008_bb0495","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1182\/blood-2007-11-122713","article-title":"Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis","volume":"111","author":"Saadoun","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.01.008_bb0500","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/ard.2007.084939","article-title":"Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy","volume":"67","author":"Quartuccio","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"10.1016\/j.autrev.2011.01.008_bb0505","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/S1590-8658(07)80023-5","article-title":"B-cell depletion in the treatment of mixed cryoglobulinemia","volume":"39","author":"Sansonno","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.autrev.2011.01.008_bb0510","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/rheumatology\/kel389","article-title":"Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication","volume":"4","author":"Quartuccio","year":"2006","journal-title":"Rheumatol Oxf"},{"key":"10.1016\/j.autrev.2011.01.008_bb0515","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1002\/art.25000","article-title":"Rituximab may form a complex with IgMk mixed cryoglobulin and induce severe sistemic reactions in patients with hepatitis C virus-induced vasculitis","volume":"60","author":"Sene","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.01.008_bb0520","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.21778","article-title":"The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial","volume":"54","author":"Emery","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.01.008_bb0525","first-page":"22","article-title":"Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases","volume":"60","author":"Zingarelli","year":"2008","journal-title":"Reumatismo"},{"key":"10.1016\/j.autrev.2011.01.008_bb0530","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.transproceed.2006.06.131","article-title":"Rituximab therapy for mixed cryoglobulinemia in seven renal transplant patients","volume":"38","author":"Basse","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.autrev.2011.01.008_bb0535","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","article-title":"Rituximab plus Peg-interferon-alpha\/ribavirin compared with Peg-interferon-alpha\/ribavirin in hepatitis C-related mixed cryoglobulinemia","volume":"116","author":"Saadoun","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.01.008_bb0540","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood-2009-10-245878","article-title":"Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study","volume":"116","author":"Dammacco","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.01.008_bb0545","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archderm.139.3.391","article-title":"Leg ulcers associated with cryoglobulinemia: clinical study of 15 patients and response to treatment","volume":"139","author":"Auzerie","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0550","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S1590-8658(00)80335-7","article-title":"Interferon versus steroids in patients with hepatitis C virus-associated cryoglobulinaemic glomerulonephritis","volume":"32","author":"Mazzaro","year":"2000","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.autrev.2011.01.008_bb0555","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V84.10.3336.3336","article-title":"Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study","volume":"84","author":"Dammacco","year":"1994","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.autrev.2011.01.008_bb0560","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1007\/BF01844200","article-title":"Deflazacort in the treatment of haematologic disorders","volume":"45","author":"Gobbi","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0565","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000236270","article-title":"Deflazacort versus prednisone in the treatment of essential mixed cryoglobulinemia a between-patient controlled clinical study","volume":"99","author":"Vacca","year":"1992","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0570","first-page":"221","article-title":"Intravenous methylprednisolone pulse therapy in essential mixed cryoglobulinemia nephopathy","volume":"19","author":"De Vecchi","year":"1983","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0575","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF02909366","article-title":"Chronic-relapsing polyneuropathy in the course of cryoglobulinemia. Clinical aspects and plasmapheretic treatment","volume":"16","author":"Caviglia","year":"1986","journal-title":"Ric Clin Lab"},{"issue":"S-13","key":"10.1016\/j.autrev.2011.01.008_bb0580","first-page":"187","article-title":"GISC protocol experience in the treatment of essential mixed cryoglobulinemia","volume":"13","author":"Pioltelli","year":"1995","journal-title":"J Clin Exp Rheumat"},{"key":"10.1016\/j.autrev.2011.01.008_bb0585","first-page":"373","article-title":"Long-term plasma exchange. Analysis of indications, outcome and side effects","volume":"145","author":"Karmochkine","year":"1994","journal-title":"Ann Med Interne Paris"},{"key":"10.1016\/j.autrev.2011.01.008_bb0590","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF02909369","article-title":"Plasma-exchange in mixed cryoglobulinemia. Effects on renal, liver and neurological involvement","volume":"16","author":"Ferri","year":"1986","journal-title":"Ric Clin Lab"},{"key":"10.1016\/j.autrev.2011.01.008_bb0595","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000183849","article-title":"Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange","volume":"43","author":"Ferri","year":"1986","journal-title":"Nephron"},{"issue":"Suppl 1","key":"10.1016\/j.autrev.2011.01.008_bb0600","first-page":"47","article-title":"Prolonged plasma exchange in the treatment of renal involvement in essential mixed cryoglobulinemia","volume":"6","author":"Bombardieri","year":"1983","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.autrev.2011.01.008_bb0605","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/039139889902200109","article-title":"Plasma-exchange in chronic peripheral neurological disorders","volume":"22","author":"Mazzi","year":"1999","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.autrev.2011.01.008_bb0610","first-page":"101","article-title":"Type II mixed cryoglobulinemia: presentation, treatment and outcome in 13 patients","volume":"82","author":"Frankel","year":"1992","journal-title":"Q J Med"},{"key":"10.1016\/j.autrev.2011.01.008_bb0615","first-page":"251","article-title":"Cryoglobulinaemia: clinical features and response to treatment","volume":"137","author":"Singer","year":"1986","journal-title":"Ann Med Interne Paris"},{"issue":"Suppl 2","key":"10.1016\/j.autrev.2011.01.008_bb0620","first-page":"19","article-title":"Long term effects of cryoapheresis and cytostatic treatment in essential mixed cryoglobulinemia","volume":"8","author":"L'Abbate","year":"1985","journal-title":"Int J Artif Organs"},{"issue":"Suppl 2","key":"10.1016\/j.autrev.2011.01.008_bb0625","first-page":"15","article-title":"Plasma exchange in the treatment of essential mixed cryoglobulinemia nephropathy. Long-term follow up","volume":"8","author":"Sinico","year":"1985","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.autrev.2011.01.008_bb0630","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02904753","article-title":"Plasma-exchange in the treatment of cryoglobulinemia","volume":"13","author":"Schena","year":"1983","journal-title":"Ric Clin Lab"},{"key":"10.1016\/j.autrev.2011.01.008_bb0635","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/22953337.1982.11718870","article-title":"Plasmapheresis combined with corticosteroids and cyclophosphamide in mixed monoclonal cryoglobulinaemia","volume":"37","author":"Verdickt","year":"1982","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.autrev.2011.01.008_bb0640","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1445-5994.1981.tb04625.x","article-title":"Glomerulonephritis secondary to mixed polyclonal cryoglobulinaemia: response to immunosuppression and plasmapheresis","volume":"11","author":"McKenzie","year":"1981","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.autrev.2011.01.008_bb0645","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/art.1780240902","article-title":"The effect of combination therapy (steroids, immunosuppressives, and plasmapheresis) on 5 mixed cryoglobulinemia patients with renal, neurologic, and vascular involvement","volume":"24","author":"Geltner","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.01.008_bb0650","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2230.1979.tb01620.x","article-title":"Essential monoclonal cryoglobulinaemia: the use of intermittent plasmapheresis to control cold induced symptoms","volume":"4","author":"James","year":"1979","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0655","first-page":"68","article-title":"Trattamento con plasmaferesi ed IVIg nella sindrome crioglobulinemica grave resistente all'IFN-alfa","volume":"52","author":"Pietrogrande","year":"2001","journal-title":"Reumatismo"},{"key":"10.1016\/j.autrev.2011.01.008_bb0660","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jca.20166","article-title":"Double-filtration plasmapheresis in the treatment of leg ulcers in cryoglobulinemia","volume":"23","author":"Ramunni","year":"2008","journal-title":"J Clin Apher"},{"key":"10.1016\/j.autrev.2011.01.008_bb0665","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Int Med"},{"issue":"Suppl 13","key":"10.1016\/j.autrev.2011.01.008_bb0670","first-page":"S197","article-title":"Colchicine in the treatment of mixed cryoglobulinemia","volume":"13","author":"Monti","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.01.008_bb0675","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.1780360522","article-title":"Colchicine and mixed cryoglobulinemia","volume":"3","author":"Invernizzi","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.01.008_bb0680","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0002-9343(89)80607-2","article-title":"Low-antigen-content diet in the treatment of patients with mixed cryoglobulinemia","volume":"87","author":"Ferri","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2011.01.008_bb0685","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF02909370","article-title":"Dietetic treatment of essential mixed cryoglobulinemia","volume":"16","author":"Pietrogrande","year":"1986","journal-title":"Ric Clin Lab"},{"key":"10.1016\/j.autrev.2011.01.008_bb0690","first-page":"65","article-title":"Therapeutical approach to the mild cryoglobulinemic syndrome: results from a retrospective cohort study","volume":"70","author":"Pietrogrande","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.01.008_bb0695","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins. A report of 86 cases","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211000231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211000231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T04:09:16Z","timestamp":1685938156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211000231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":139,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1568997211000231"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.01.008","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}